Skip to main content
In Memoriam: David J. Galas, Ph.D. (1944-2023) >>
Hide alert
About Us
History & Overview
Our Team
Research Services
Venture Analysts
Venture Center
Our Partners
Grants
Accelerating Innovation
Technology Commercialization
Postdoctoral Fellowships
Student Programs
Building the Innovation Ecosystem
Submit Phased Grant Pre-Proposal
Recent Grants
Startup Investments
Investing in Washington
Active Portfolio & Exits
Stories
News
Articles
Videos
Reports
Contact
Close
Keywords:
Search
Toggle Search
Toggle mobile menu
Nohla Therapeutics raises $45M, gets new HQ as it moves novel leukemia treatment closer to market
Post navigation
←
Proniras Corp. launches in Seattle, scores $89.5 million contract to develop new seizure drug
Five years later, 86 percent of patients are cancer-free thanks to Nohla Therapeutics’ leukemia treatment
→
Comments are closed.
About Us
History & Overview
Our Team
Research Services
Venture Analysts
Venture Center
Our Partners
Grants
Accelerating Innovation
Technology Commercialization
Postdoctoral Fellowships
Student Programs
Building the Innovation Ecosystem
Submit Phased Grant Pre-Proposal
Recent Grants
Startup Investments
Investing in Washington
Active Portfolio & Exits
Stories
News
Articles
Videos
Reports
Contact
Close menu
